Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Von Willebrand Factor Gene Variants Associate with Herpes simplex Encephalitis

N. Abdelmagid, B. Bereczky-Veress, S. Atanur, A. Musilová, V. Zídek, L. Saba, A. Warnecke, M. Khademi, M. Studahl, E. Aurelius, A. Hjalmarsson, A. Garcia-Diaz, CV. Denis, T. Bergström, B. Sköldenberg, I. Kockum, T. Aitman, N. Hübner, T. Olsson,...

. 2016 ; 11 (5) : e0155832. [pub] 20160525

Language English Country United States

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc17031707

Herpes simplex encephalitis (HSE) is a rare complication of Herpes simplex virus type-1 infection. It results in severe parenchymal damage in the brain. Although viral latency in neurons is very common in the population, it remains unclear why certain individuals develop HSE. Here we explore potential host genetic variants predisposing to HSE. In order to investigate this we used a rat HSE model comparing the HSE susceptible SHR (Spontaneously Hypertensive Rats) with the asymptomatic infection of BN (Brown Norway). Notably, both strains have HSV-1 spread to the CNS at four days after infection. A genome wide linkage analysis of 29 infected HXB/BXH RILs (recombinant inbred lines-generated from the prior two strains), displayed variable susceptibility to HSE enabling the definition of a significant QTL (quantitative trait locus) named Hse6 towards the end of chromosome 4 (160.89-174Mb) containing the Vwf (von Willebrand factor) gene. This was the only gene in the QTL with both cis-regulation in the brain and included several non-synonymous SNPs (single nucleotide polymorphism). Intriguingly, in human chromosome 12 several SNPs within the intronic region between exon 43 and 44 of the VWF gene were associated with human HSE pathogenesis. In particular, rs917859 is nominally associated with an odds ratio of 1.5 (95% CI 1.11-2.02; p-value = 0.008) after genotyping in 115 HSE cases and 428 controls. Although there are possibly several genetic and environmental factors involved in development of HSE, our study identifies variants of the VWF gene as candidates for susceptibility in experimental and human HSE.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17031707
003      
CZ-PrNML
005      
20171025123125.0
007      
ta
008      
171025s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0155832 $2 doi
035    __
$a (PubMed)27224245
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Abdelmagid, Nada $u Department of Clinical Neuroscience, Neuroimmunology Unit, Karolinska Institutet, Karolinska University Hospital, SE-171 76 Stockholm, Sweden. $7 gn_A_00000341
245    10
$a Von Willebrand Factor Gene Variants Associate with Herpes simplex Encephalitis / $c N. Abdelmagid, B. Bereczky-Veress, S. Atanur, A. Musilová, V. Zídek, L. Saba, A. Warnecke, M. Khademi, M. Studahl, E. Aurelius, A. Hjalmarsson, A. Garcia-Diaz, CV. Denis, T. Bergström, B. Sköldenberg, I. Kockum, T. Aitman, N. Hübner, T. Olsson, M. Pravenec, M. Diez,
520    9_
$a Herpes simplex encephalitis (HSE) is a rare complication of Herpes simplex virus type-1 infection. It results in severe parenchymal damage in the brain. Although viral latency in neurons is very common in the population, it remains unclear why certain individuals develop HSE. Here we explore potential host genetic variants predisposing to HSE. In order to investigate this we used a rat HSE model comparing the HSE susceptible SHR (Spontaneously Hypertensive Rats) with the asymptomatic infection of BN (Brown Norway). Notably, both strains have HSV-1 spread to the CNS at four days after infection. A genome wide linkage analysis of 29 infected HXB/BXH RILs (recombinant inbred lines-generated from the prior two strains), displayed variable susceptibility to HSE enabling the definition of a significant QTL (quantitative trait locus) named Hse6 towards the end of chromosome 4 (160.89-174Mb) containing the Vwf (von Willebrand factor) gene. This was the only gene in the QTL with both cis-regulation in the brain and included several non-synonymous SNPs (single nucleotide polymorphism). Intriguingly, in human chromosome 12 several SNPs within the intronic region between exon 43 and 44 of the VWF gene were associated with human HSE pathogenesis. In particular, rs917859 is nominally associated with an odds ratio of 1.5 (95% CI 1.11-2.02; p-value = 0.008) after genotyping in 115 HSE cases and 428 controls. Although there are possibly several genetic and environmental factors involved in development of HSE, our study identifies variants of the VWF gene as candidates for susceptibility in experimental and human HSE.
650    _2
$a zvířata $7 D000818
650    _2
$a savčí chromozomy $x genetika $7 D033481
650    _2
$a herpetická encefalitida $x genetika $7 D020803
650    _2
$a genotypizační techniky $7 D060005
650    12
$a lidský herpesvirus 1 $7 D018259
650    _2
$a lidé $7 D006801
650    12
$a jednonukleotidový polymorfismus $7 D020641
650    12
$a kvantitativní znak dědičný $7 D019655
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani inbrední SHR $7 D011918
650    _2
$a von Willebrandův faktor $x genetika $7 D014841
655    _2
$a časopisecké články $7 D016428
700    1_
$a Bereczky-Veress, Biborka $u Department of Clinical Neuroscience, Neuroimmunology Unit, Karolinska Institutet, Karolinska University Hospital, SE-171 76 Stockholm, Sweden.
700    1_
$a Atanur, Santosh $u Division of Medicine, Imperial College London, London, United Kingdom. $7 gn_A_00009709
700    1_
$a Musilová, Alena $u Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
700    1_
$a Zídek, Václav $u Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
700    1_
$a Saba, Laura $u Department of Pharmacology, University of Colorado, Denver School of Medicine, Denver, United States of America.
700    1_
$a Warnecke, Andreas $u Department of Clinical Neuroscience, Neuroimmunology Unit, Karolinska Institutet, Karolinska University Hospital, SE-171 76 Stockholm, Sweden.
700    1_
$a Khademi, Mohsen $u Department of Clinical Neuroscience, Neuroimmunology Unit, Karolinska Institutet, Karolinska University Hospital, SE-171 76 Stockholm, Sweden.
700    1_
$a Studahl, Marie $u Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
700    1_
$a Aurelius, Elisabeth $u Department of Medicine, Unit of Infectious Diseases, Karolinska Institutet, Karolinska University Hospital, SE-171 76 Stockholm, Sweden. $7 gn_A_00010143
700    1_
$a Hjalmarsson, Anders $u Department of Medicine, Unit of Infectious Diseases, Karolinska Institutet, Karolinska University Hospital, SE-171 76 Stockholm, Sweden.
700    1_
$a Garcia-Diaz, Ana $u Division of Medicine, Imperial College London, London, United Kingdom.
700    1_
$a Denis, Cécile V $u Institut National de la Santé et de la Recherche Médicale UMR_S 1176, Univ. Paris-Sud, Université Paris-Saclay, 94276 Le Kremlin-Bicêtre, France.
700    1_
$a Bergström, Tomas $u Department of Clinical Virology, University of Gothenburg, SE-413 46 Gothenburg, Sweden.
700    1_
$a Sköldenberg, Birgit $u Department of Medicine, Unit of Infectious Diseases, Karolinska Institutet, Karolinska University Hospital, SE-171 76 Stockholm, Sweden.
700    1_
$a Kockum, Ingrid $u Department of Clinical Neuroscience, Neuroimmunology Unit, Karolinska Institutet, Karolinska University Hospital, SE-171 76 Stockholm, Sweden.
700    1_
$a Aitman, Timothy $u Division of Medicine, Imperial College London, London, United Kingdom. $7 gn_A_00002731
700    1_
$a Hübner, Norbert $u Max-Delbruck-Center for Molecular Medicine, Berlin-Buch, Berlin, Germany.
700    1_
$a Olsson, Tomas $u Department of Clinical Neuroscience, Neuroimmunology Unit, Karolinska Institutet, Karolinska University Hospital, SE-171 76 Stockholm, Sweden.
700    1_
$a Pravenec, Michal $u Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
700    1_
$a Diez, Margarita $u Department of Clinical Neuroscience, Neuroimmunology Unit, Karolinska Institutet, Karolinska University Hospital, SE-171 76 Stockholm, Sweden.
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 11, č. 5 (2016), s. e0155832
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27224245 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20171025 $b ABA008
991    __
$a 20171025123207 $b ABA008
999    __
$a ok $b bmc $g 1255300 $s 992734
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 11 $c 5 $d e0155832 $e 20160525 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20171025

Find record

Citation metrics

Archiving options